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IgM autoantibodies that bind the constant region ofIgG (IgM anti-IgG) are a
normal physiological component of secondary immune responses in a number of
species, including mouse and human (1-3). Such antibodies have been termed
rheumatoid factors (RF),' owing to their original identification in the serum of
rheumatoid arthritis patients, who constitutively produce RF (4). In the mouse,
it has been shown that immune complexes formed during the course of a
secondary immune response toa variety ofprotein antigens canstimulatenormal
B cells to produce IgM anti-IgG in a Thelper cell-dependent manner (5, 6). In
a secondary immune response to protein antigens, the quantity of IgM anti-IgG
can equal or exceed the amount ofantigen-specific antibody (2).
The fraction of B cells that can produce this autoantibody may also be very
high; 3-10% of hybridomas derived from mice stimulated with the nonspecific
B cell mitogen bacterial lipopolysaccharide (LPS) produce IgM that bind IgG
(7). Our previousanalysis ofthe variable region sequence ofnine such antibodies
suggested that a large number of different germline V genes, in association
with a variety of DH, J., and JK could be used in combination with a limited set
ofVK genes to encode the RF specificity (8). We proposed that this pattern of V
gene expression could account for the high frequency ofB cells that can produce
IgM that binds IgG.
It has been suggested that the large fraction of LPS-activated B cells that make
IgM anti-IgG is the reason for the large quantity of RF secreted during the
secondary immune response (5, 6). However, an alternative model is that only a
subset of the cells found among LPS-derived IgG-binding IgM antibodies are
stimulated to produce RF in vivo during a secondary immune response. A
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CDR, complementarity-determining region; FR, framework
region; RF, rheumatoid factor.
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prediction of the first model is that the V regions expressed in the two types of
RF should be similar. To allow a significant comparison ofthe V region structures
of these two types of RF, we have analyzed 15 additional antibodies, providing
a database of 10 LPS- and 14 secondary protein immunization-derived RFs. In
this sample, the variable regions of IgG-binding IgM antibodies isolated after
LPS stimulation are similar from those of RFs derived after secondary immuni-
zation with protein . This supports the idea that the large quantity ofRF produced
during the secondary immune response is attributable to a large number of B
cells that can make this antibody . In addition, the new sequence data confirm
and extend our earlier findings concerning V region usage in RFs, and provide




The VS and RF series of hybridomas were described previously, as were
JV2 and JV6 (8) . The remaining JV series hybridomas were produced by fusion with
SP2/0 and tested by ELISA and particle agglutination assays as described (3) . The A and
B series hybridomas were produced by fusion with the nonsecreting cell line PAID (M .
Brockhaus, personal communication) and tested by hemolysis assay and by RIA that
detected bound IgM . All hybridomas bind IgGl ; some hybridomas bind other murine
isotypes and some types of heterologous IgG, as is commonly found among IgM anti-
IgG 1 (3, and D . Nemazee and J . Van Snick, unpublished observation) . Hybridomas were
derived from spleens of mice stimulated either by in vivo LPS injection or by secondary
immunization with antigenic protein (Table I). With the exception of the A series of
hybridomas, RF hybridomas sequenced here or reported elsewhere react with the im-
munizing protein . The A series hybridomas did not react with arsonate-coupled red blood
cells (Ars-RBC), but have not been assayed on Limulus polyphemus hemocyanin-Ars
(LPH)-Ars. Spleen cells were derived from BALB/c mice (IgH') except forJV3JV5 and
JV8JV10, which were from 129/Sv mice (IgH') .
Sequence Determinations of Variable Regions of Ig mRNA .
￿
Growth of cells, preparation
of RNA, production of labelled cDNA, and chemical degradative sequencing reactions
were performed as described (8) . Briefly, we used poly(A)-enriched RNA from hybridoma
cells as a template for synthesis of full-length cDNA primed by 5'-labelled oligonucleotides
that hybridized to the constant portions of either the is (CK primer) or A (C primer)
mRNAs at a site just 3' of the V-C junction . The full-length cDNA was isolated on a
polyacrylamide gel, eluted, and subjected to chemical degradative sequencing reactions .
The resolution of the labelled cDNA fragments generated by these reactions on three
types of polyacrylamide sequencing gels usually resulted in the unambiguous assignment
of virtually all nucleotides up to ^-400 bases from the priming site .
Results
15 IgM anti-IgG 1 hybridomas were selected at random from RF hybridoma
libraries assembled from several fusions performed in two laboratories . These
are described in Table I . RNA from these cell lines was prepared and sequenced
as described in Materials and Methods . The nucleotide sequences were read
from autoradiograms of three overlapping gels and were translated to amino
acid sequences using the universal genetic code .
Fig. 1 shows theamino acid sequences ofthe K light chains of the 15 hybridomas
along with similarly derived data from 9 hybridomas described earlier. Fig . 2
shows the heavy chain sequences grouped according to the type of light chain
with which each is paired (see Discussion) . For reference, the corresponding972
￿
VARIABLE REGION SEQUENCES OF RHEUMATOID FACTORS
TABLE I
Summary ofSequence Characteristics ofIgM Anti-IgG1 Sequences
JV cell lines were produced by J. Van Snick; A and B lines by D. Nemazee. VS and RF cell lines
were described previously, as were JV2 and JV6. Classification of the V region segments is as
described in Results.
* DxS04, dextran sulfate; Alf-DNP, human apolactoferrin coupled with dinitrophenyl groups; Trf,
human transferrin; LPH-Ars, arsonate conjugated to Limulus polyphemus hemocyanin.
$V. group number designations are according to Potter et al. (10); the small letters are arbitrary
additionsthat distinguish different genesfrom the same family. For V,1 andV,24, the letters used
correspond to thedesignations used by otherauthors forthe same sequenceswhen applicable (JV6,
VS1, and A5).
J, genesare numbered 1-4 in the order5' -> 3' with respect to the constant region coding strand;
thepseudogene (3 in other numbering systems) is skipped in this system.
Ddesignations aredescribedin thetext. The A9 Vsequence hascontiguous regions ofhomology
to both SP2.2 and FL16.1 . NA, not assignable to known gene.
CDR3 length is definedas the number of aminoacidsbetweenthe last codon of FR3 (the invariant
Arg residue) and the invariant Trp residue coded for by each of theJ genes.
nucleic acid sequences are given in Figs. 3 and 4. The sequence of VS3 (8) is
revised, and we report a partial sequence for the RF49 heavy chain.
To relate the RF V,, and V, sequences to other known sequences, we have
classified each V region segment using the categories developed for V by
Brodeur and Riblet (9) and for V, by Potter et al. (10) (Table 1). V sequences
are assigned to a group on the basis of 380% homology to prototype sequences
from that family. By this criterion, the sequence ofthe V inJV9 (Fig. 2) defines
Cell Derivation*
group*
J.0 Vh family D.,1 J" Cngth'
JV3 LPS Id 2 J558 FL16.2 4 7
JV2 LPS/DXS04 8a 1 J558 NA 2 7
JV4 LPS 8a 1 J558 SP2.3,.4,.6 4 7
JV5 LPS 8a 4 J558 NA 2 7
VS3 LPS 86 2 J558 NA 4 8
VS4 LPS 8a 1 J558 FL16.1,.2 3 7
RF34 LPS 19c 2 J558 SP2 (any) 4 8
RF49 LPS 19a 2 J558 NA 2 9
RF49b LPS l9b 2 - - - -
RF51 LPS 19a 2 J558 SP2.3,.4,.6 2 8
B13 LPS 23a 2 PC7183 SP2.1-.7 2 11
JV6 Alf-DNP lc 1 J558 FL16.1,.2 4 9
VS1 KLH lc 1 J606 Q52 3 8
A9 LPH-Ars 4a 2 PC7183 SP2.2 and FL16.1 2 13
JV9 Trf 4b 3 Sm7 NA 4 7
A12 LPH-Ars 8c 2 J558 FL16 2 8
A17 LPH-Ars 8d 2 J558 SP2.5,.7 3 9
JV10 Trf Se 2 Q52 SP2.3,.4,.6 4 9
A23 LPH-Ars 19d 4 PC7183 SP2.5,.7,.8 2 11
A34 LPH-Ars 19d 1 J558 FL16.2 4 8
JV8 Trf 19d 3 PC7183 FL16.1' 3 12
VS2 KLH 19d 1 PC7183 FL16.1 1 10
A26 LPH-Ars 23a 1 PC7183 Q52 3 11
A15 LPH-Ars 24c 2 J558 SP2.5,.7,.8 4 8
A5 LPH-Ars 246 1 J558 FL16.2 4 8~ ~~ ~ 'T~}' b0 Id u toL CV C,~ O b
C O v 3 "-
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a new family, which we refer to as Sm7, after an anti-Sm hybridoma in which we
first sequenced a V gene from this family (our unpublished data). Genes in this
family do not have the invariant lysine residue at the 13th position, and are one
residue shorter in the first framework region (FR1) (numbering and region
designation as described in Kabat et al . [I 1 ]) .
TheVK groups describedby Potter et al . (10) are basedon amino acid sequence
homology over the NH3-terminal residues. A linking algorithm defined groups
that had 12 or fewer differences over the first 41 residues . We have used this
amino acid homology criterion to assign sequences to existing groups . Use of
:80% nucleic acid homology would not have resulted in different assignments .
Classification of JH and JK is according to identity with the germline genes of
BALB/c (12, 13). Classification of D is according to the best match with the
known germline Ds ofBALB/c (14) ; where ambiguity exists, all possibilities are
listed in Table 1 .
Analysis of the nucleotide sequence data and Southern blot data (not shown)
has allowed a tentative determination of whether related sequences belonging to
the sameVK group derive from the same VK germline gene . The data show that,
for each VK group found among RFs (exceptVK23), multiple germline genes are
used . The subclassification of the sequences according to presumptive germline
genes is indicated in Table I. Sequences classified as coming from the same
germline gene are either identical or have one (putatively somatic) difference at
thenucleotide level. Genes classified as unique have 10-30nucleotide differences
from their closest relative ; in many cases, two or more independent isolates of
the same sequence confirms the distinction between it and its nearest relative .
Detection of restriction enzyme map differences in Southern blotting analysis of
representative hybridomas (not shown), supports the distinctions made by nucleic
acid homology criteria . Among 25 RF VK sequences, we have observed four
genes belonging to the VK8 homology group, four from the VK19 group, two
from the V. I group (15), two from the VK24 group (16), and two from the VK4
group .
The large size of the V,, J558 family (9), which may contain many nearly
identical germline genes (17), prevents assignment of theJ558 sequences on the
basis of repeats . Unlike the V,, sequences of RF, which contain many cases of
repeats of the same sequence, there are 12 different V J558 family sequences
among 15 RF examples (Fig . 1) . On the other hand, the selection of genes from
the 7183 family may be nonrandom, as only 2 different sequences are found in
6 examples ; there are estimated to be 10-12 germline genes in this family . The
possible implications of the patterns ofV and VK gene expression in RFs will be
discussed below .
Discussion
We have determined the complete V region sequencesof 11 secondary protein
immunization- and 5 LPS-derived RFs . These sequences, along with those
already published, now provide a database large enough to permit a valid
comparison of the two types of RFs . This comparison allows us to distinguish
between models of the genetic control of RF production during the secondary
immune response (see below) . In addition, as discussed below, these data supportU I I I I I < I «««<
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our previous conclusions about V gene usage in RFs. Finally, we discuss the
homologies among these V regions and how they define sites on RF molecules
that may determine specificity.
The Pattern of V Region Expression in IgM Anti-IgG.
￿
Information about V
region usage in RFs could provide insight into the reason for the high frequency
ofB cells that can make RF. Analysis of RF sequences for patterns of V region
expression shows that a select subset of light chains is found, but there is
remarkable diversity in the selection ofthe other variable region elements. This
analysis consists oftesting whether each VH family or VK groupis expressed more
frequently in the RF population than would be expected randomly, using a
binomial probability model. For each hybridoma, we assign the sequences to V
groups and VK families, as described in Resultsandsummarized in Table I. These
classification systems reflect the V and VK gene organizations, which, briefly,
are as follows: the VH germline genes fall into ^-10 sequence homology families,
each containing from a few to perhaps hundreds of genes (9, 18). The V,, J558
family appears to include at least 60% of the genes; the V7183, VJ606, and
VHQ52 families each contain at most 10% of the genes. The 100-200 VK genes
are organized into ^-30 groups, which each contain ^-1-10 genes (10, 19). The
levelofexpression foreach grouporfamily isnotknownpreciselybutis estimated
from the fraction of germline genes that a given sequence group occupies. This
estimate is reasonable because, in general, the expression ofthese genes in adults,
as assayed in myelomas, LPS hybridomas, and serum, is concordant with their
representation in the germline (20-22).
Statistical analysis of light and heavy chain representation shows that the
selection oflight chains, but not heavy chains, is significantly nonrandom among
RFs. Each of three light chain types, VK1, VK8, and V,,19 is found in our RF
sample significantly more frequently than could be explained by random fluctua-
tion (p < 0.05 for each). On the other hand, the representation of each of the
V families is consistent with random selection of VHs from the available gene
pool. The large number ofV.J558-expressingRF hybridomas does not represent
over-expression, because this single large family makes up ^-60% of the unse-
lected pool (21). Moreover, as inferred from sequence and Southern blot data
(not shown) we have found at least 12 different members of the J558 family,
suggesting that there is not selection for a particularJ558 gene or subset ofthe
J558 family. Genes from the VH7183 family, which occur in 6 of 24 RFs, may
be slightly overrepresented (p = 0.03) compared with the randomly expected
value of ^-10% (the approximate fraction of the germline gene pool that it
occupies). We have so far observed only five VH families, which together encom-
pass 80-90% ofV,, germline genes. The failure to observe the fiveother families
may mean that not all VHs are suitable for generating anti-IgGs; but, because the
gene families ofthe VH types we have not observed are small, the results of the
current survey could also be attributed to the sample size. TheJKs, Do, andJHs
include examples of all the known germline types, and there is no discernible
pattern to their expression . The heavy chain complementarity-determining re-
gion 3 (CDR3) length varies from 7 to 12 residues. These latter elements do not
seem to be conserved features ofanti-IgGI sequences.
Most important, highly divergent VHs from different familiesare found pairedSHLOMCHIK ET AL .
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with similar light chains for each of the dominant VK1, VK8, and VK19 groups
(compare VS 1 andJV6, A17 andJV10, andA34 and JV8 V sequences, Fig . 2) .
Moreover, where more than one member of the same VH sequence group (e.g .,
J558) is found paired to VKs of the same family, these include multiple different
members of that family (for example, compare JV3 and JV6, Fig. 2) . The
patterns of V region expression suggest a rule for the constitution of the anti-
IgGI specificity : the presence of any one of a subset of light chains (VK1, VK8,
and V,19), in combination with a variety of VH, DH, JH, andJK seems sufficient to
generate the capacity to bind IgG1 . This rule can be used to make a rough
estimate of the number of B cells that would rearrange the correct genes to
make an RF antibody . This number can be calculated as the product of the
fractions of VH, D,,, JH, VK, andJK regions that are suitable for the constitution of
IgG binding . Ifone assumes, as suggested by the data, that a high fraction ofVH,
DH, J., and JK regions are suitable, then the percentage of B cells that have the
RF specificity approaches the percentage of B cells expressing the correct VK
genes. Using similar assumptions, we previously calculated this to be 5-17% of
B cells . This compares favorably with the percentage of nonspecifically activated
B cell hybridomas that make RF : 3-10% .
It is important to point out that this patten ofV region expression is not typical
ofantibodies to other antigens . The most striking contrast comesfrom antibodies
to small molecules (haptens) conjugated to protein carriers . Antibodies to haptens
are often quite homogeneous, comprising restricted combinations of V region
elements (VH , DH, JH, V,,, and JL) (17, 23). The extreme example of this is the
dominant antibody of the A/J mouse immune response to p-azophenylarsonate
(Ars), composed of a unique combination ofVH, DH, JH, VK, andJK segments (23) .
The likelihood ofjoining the required combination of segments in the same cell
is low for such restricted responses . For the dominant anti-Ars response, it has
been estimated that this event occurs in only 1 in 4 x 107 B cells (23) .
RFs also seem different from antibodies to other protein antigens . Proteins
can contain several different antigenic epitopes on their surface that are in some
ways analogous to haptens . The immune responses to many protein epitopes
have not displayed the same level of restriction as found forantihapten responses
(24, 25). Typical restrictions that seem to govern the construction of antiprotein
antibodies are illustrated by one set of hemagglutinin-specific antibodies (C4)
frequently found in the primary response to influenza . In this case, the V,-J,
combination is always the same, and the selection of VH, though not always the
same, is also clearly not random, in that three of five cases studied used a single
germline gene (S . Clarke et al ., manuscript in preparation) . Thus, antibodies to
some protein epitopes can be less homogeneous than antihapten antibodies but
more homogeneous than IgM anti-IgG autoantibodies.
The Structures ofRFs Derived from Nonspecific Activation Are Similar to Those
Derived by Antigen Elicitation. The reason for making this comparison is to test
the idea that the strong magnitude of the RF response during secondary protein
immunization is related to thehighnumber ofB cells that can make that response,
as suggested by the high frequency of RF-producing B cells activated by LPS .
This idea implies that the two types are drawn from the same pool and predicts
that the types of sequences found in LPS-derived and antigen-elicited RF anti-982
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bodies will be similar. This, however, need not be the case. An in vitro immu-
noassay was used to detect the LPS-derived hybridomas that made IgM anti-IgG,
whereas in vivo B cell activation by antigen was the criterion for generating
secondary protein immunization-derived RF. A second model states that possibly
the antigen-antibody interactions measurable in such an in vitro assay would not
be sufficient to cause B cell triggering in vivo. If this were the case, then one
would expect that many of the structures found in LPS-derived RF would have
no counterpart in the secondary protein immunization-elicited RFs, because
these structures would not have sufficient affinity for IgG constant region to
mediate B cell activation.
These sequence data are consistent with the first model. Each LPS-derived
hybridoma in our sample has a counterpart, with similar VH and V,, sequences,
among the group of secondary protein immunization-derived RF. 10 of 14
secondary protein immunization-derived RFs have sequences similar to those
found in the LPS-derived RF sample. This suggests that most of the LPS-
activated B cells that produce IgM anti-IgG could be precursors of the cells
stimulated in vivo by IgG-containing immune complexes. Because it is known
that a large fraction of LPS-activated B cells can produce RF, it is thus quite
likely that the strong magnitude of the normal physiological RF response after
secondary immunization with protein antigen is attributable to the presence ofa
large number of immune complex-activatible B cells.
For the foregoing analysis, it is only important to know whether the types of
sequences found among LPS-derived RF are present among secondary protein-
derived RF as.well. A related question is whether the two groups are in fact the
same in sequence composition. We have carried out X2 analyses to test this
statistically. With the current data, we cannot rule out the null hypothesis that
the LPS- and secondary, protein-derived RFs are the same in sequence compo-
sition for V (p = 0.22) or VK (p = 0.42) as a whole, nor can we rule out that the
representation ofany single V or VK type is the same between the two groups
ofhybridomas (all p > 0.05, Fisher's exact test).
Nonetheless, it is important to note that some Vs and some VKs have been
observed so far only in the secondary protein-derived hybridomas. Should, in a
larger sample, these differences attain significance, it would be tempting to
invoke selection by antigen as an explanation. It may be that RF stimulation by
IgG-containing antigen-antibody complexes will result in the differential expan-
sion of RF precursors; cells with higher-affinity receptors might be induced to
divide more frequently. In this case, one might not expect the effects ofselection
for clones that bind antigen better to be very dramatic for RFs derived from
animals immunized twice with protein, as the RF response in this context is
analogous to a primary immune response. In fact, the data do not show strong
selection effects; most (10 of 14) of the antigen-elicited RFs that we have
sequenced do resemble the nonspecifically stimulated RFs. It will be interesting
to see the effects ofmore protracted antigenic stimulation of RFs. Somediseased
mouse strains carrying the 1pr gene do make RF spontaneously, possibly as a
result ofcontinuous stimulation by immune complexes found in these mice. The
population of RFs found in these mice may show stronger evidence of theSHLOMCHIK ET AL.
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influence of selection by antigen. Determination of the primary structures of
antibodies ofthis type should help to address this question.
Regions of Sequence that Are Conserved among RFs.
￿
Analysis of primary se-
quence data hasoften yieldeduseful informationaboutthestructure and function
of antibodies. For example, Wu and Kabat (26) compared variable region
sequences from a collection of unrelated Igs and noticed regions of primary
sequence that were highly variable. Theseregionswere inferred tobe responsible
for the unique specificity of individual antibodies. Since then, many others (17,
23, 24) have analyzed sequences of antibodies that bind the same antigen.
Conversely, such antibodies of similar specificity proved to be identical at many
residues that were hypervariable among randomly chosen antibodies. These
shared residues were implicated in determining the shared antigen specificity;
the importance ofsuch residues has been shown directly in some cases (27, 28).
Contact residues of Ig V regions are thus expected to be conserved among
antibodies ofthe same specificity. The nonrandom pattern ofVK representation
and the fact that many hybridomas share very significant VK sequence homology,
suggests that VK isplayingan important role in determiningtheantigen specificity
of RFs. Conversely, it is difficult to imagine, based on the extent of amino acid
divergence among V sequences associated with VKs of the 1, 8, and 19 groups,
that the heavy chain is contributing to many, if any, contacts with antigen in
these antibodies.
We therefore have focused on RF light chainamino acid sequences; previously
we asked whether there are specific regions of sequence that are shared among
many or all RF antibodies. To our surprise, we noticed that FR2 and FR3 ofall
sequences from VK1, VK8, and VK19 are highly similar compared with the same
regions in VK sequences from other families (see Shlomchik et al. [8] for detailed
analysis). The same analysis did not show any CDR or FR1 conservation between
families. We therefore hypothesized that FR2 and FR3 may be involved in
binding IgGI . This model is physically plausible, as these regions are on the
surface of the VK domain. By this model, antibodies expressing VKs from any one
ofthesethreefamilieswill bind IgG1 inasimilar (though not necessarily identical)
fashion, perhaps through an interaction between broad surfaces ofthe VK domain
and an IgGI constant domain (most likely CH3 [29]).
Further support for this model has emerged from three features of RF V
region sequences that have become apparent from the present data. First is the
fact that multiple germline genes from each of the VK groups can be expressed
in RFs. Different genes in a VK family are often quite divergent in CDR but tend
to resemble each other strongly in the FR regions (11). For example, compare
the VK8 sequences of A17, JV10, VS3, and JV2 (Fig. 1). Thus, the pattern of
FR2/3 conservation and CDR divergence noted in interfamily light chain com-
parisons is recapitulated in intrafamily sequence comparisons. Second, whereas
previously we noted widely divergent VHs paired just with VK1 and VK19 chains,
a prediction of the framework binding site model is that multiple types of V
could also associate with V.8-type light chains in RFs. The newly determined
sequences ofJV10, in which a VK8 light chain is paired with a VHQ52 heavy
chain satisfies this prediction. Third is the finding of two VK24 light chains in
antibodies A5 and Al5. These two sequences (Fig. 1), although formally in the984
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VK24 group, are quite similar to VK1 sequences, particularly in FR2 and FR3 (as
evident in Fig. 1). The levels of framework homologies are comparable to the
homology between the two members of V,;1 itself. In addition, as found for VK1,
VK8, and V,19 RF sequences, the two observed members ofthe VK24 family stem
from two distinct germline genes and differ substantially in CDRs (Fig. 1).
Although VK is implicated as most important in supplying antigen contact
residues, subtle features ofthe datado indicate a role for VH in the determination
of the specificity of these antibodies. Most striking is the example ofJV4 and
JV12, which express identical light chain sequences. The only structural differ-
ences between these antibodies are in the heavy chain, yet JV4 is specific for
IgG1 while JV12 binds IgG2a of the a allotype but not IgG1 (JV12 sequence
and binding data not shown). Although the antibodies use different members of
theJ558 family, it is notable thatJV12 heavy chain has an unusually long CDR3,
of 16 residues. Similar examples that bind IgG2a and not IgG1 occur with
antibodies expressing VK1 light chains and expressing VK19 light chains (not
shown). The effects ofV on specificityneednot, in principle, be mediated solely
through direct antigen contact (27). Different V sequences could affect the
folding or shape of light chains. Or, certain VHs might contain residues or CDR
loop lengths that sterically prevent association of V,1-, VK8-, VK19-, or V,24-
expressing antibodies with some types of IgG constant regions (e.g.,JV12).
An alternative model that can account for VK restriction is that hybridomas
expressing VK sequences from the same group bind in a similar way using the
classical, CDR-encoded binding site. The lack of restriction on V and the use
of multiple VK members from each family could be attributed to the relatively
low affinity ofRF antibodies, which might permit less stringent sequence require-
ments for these antibodies. In this model, each VK group would presumably
define a different epitope on IgGI. While we do not favor this model for
explaining the VK1, VA VK19, and VK24 sequences, we think it does account
well for someofthe infrequently observed sequence types. Hybridomas A26 and
B13 express identical VK23 sequences; use the same VH7183 gene, and have the
same VH CDR3 length. These could represent the type of antibodies that use
CDR residues to bind a different epitope ofthe IgGI constant region. Asecond
pair of antibodies, JV9 and A9, use different genes belonging to the VK4 light
chain group and express VHs from two different families. Two other anti-IgG
antibodies that use members of the VK4 family use VHs from two additional
families (our unpublished observations). This pattern of VK and VH usage is
reminiscent of that seen in the VK1, VA V,19, and V.24-expressing RFs.
However, in FR2 and FR3, the VK4 sequences are somewhat different from the
other four VK groups. It is tempting to speculate that RFs expressing VA genes
represent another strategy for using FRs to bind IgG.
Regardless of the exact nature of the interaction between RF and IgG, the
major conclusion of this study, that the two differently derived types of RF are
structurally similar, has important implications for the etiology and function of
RE This result establishes a connection between the antibodies measured in the
LPS responseand those elicited by secondary immunization with protein antigen.
The high frequency of these biologically relevant precursors could, in turn,SHLOMCHIK ET AL.
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explain the very rapid and prolific nature of RF production accompanying a
secondary immune response.
Thus, the capability to produce auto-IgM anti-IgG seems to be an inevitable
result of the fact that murine RF antibodies are encoded by a relatively large set
of VK germline genes in combination with a variety of V,, genes. The presence
of these germline genes may indicate an evolutionary selection for and an
adaptive value of the ability to produce large amounts of RF during a secondary
immune response. Others have suggested roles for normal RF in enhancing
complement fixation and immune complex clearance (2, 3), and have demon-
strated its role in protection against Trypanosoma lewisi in rats (30). Further, in
humans, as in the mice, there is evidence that RFs are encoded by a limited set
of light chains in combination with a variety of heavy chains (31). Here, too, a
similarstrategy for providinga high frequency of B cells that express what might
be a critical specificity may be used.
Summary
We have obtained the complete variable region mRNA sequences of 11 LPS-
derived and 14 secondary immunization-derived monoclonal IgM anti-IgG
antibodies (rheumatoid factors, RFs). A comparative analysis of these sequences
showed that monoclonal RFs derived after polyclonal activation are structurally
very similar to RFs derived after secondary protein immunization . This study
was undertaken to evaluate the potential relationship between two previously
described phenomena: (a) during a secondary response to a protein antigen, RF
is produced in quantities that equal or exceed the immunogen-specific antibody;
and (b) the frequency of B cells that make RF after polyclonal activation is quite
high; 3-10%. It has been unclear whether LPS-stimulated cells that produce
IgM anti-IgG that is detected by an in vitro assay are related to the cells that
produce RF after in vivo stimulation. The similarity of the antigen receptors
found in the two types of RF, however, suggests that most or all of the RF-
producingB cells detected after LPSstimulation wouldalso be stimulated during
the secondary immune response. Thus, the presence of relatively large number
of B cells that can make RF after nonspecificstimulation provides an explanation
for the magnitude of RF production accompanying the secondary immune
response.
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